EUCLYD
EUCLYD is developing custom AI processors, memory architectures and data-centre systems designed to make large-scale AI inference more power- and cost-efficient.
>€200MSeries A
LeadSE
Scaleup Europe Fund
Activity from announced rounds
Activity in this selectionOct 6, 2026 · AI · Sep 7, 2026
Scaleup Europe Fund is the EQT-managed fund explicitly named in EUCLYD, Tandem and Mistral announcements.
Recorded funding activity
EUCLYD develops processors and memory for inference. Tandem automates clinical documentation, while Mistral supplies models and computing infrastructure. This named fund remains separate from EQT Ventures, EIC Fund and earlier manager-level activity.
- Rounds participated in
- 3
- Confirmed lead rounds
- 3 All roles disclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $3.6B 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionTandem Health
Tandem builds an AI clinical assistant that turns patient consultations and clinician dictation into draft notes and follow-up documents for review in existing medical-record systems.
$100MSeries B
LeadMistral AI
Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.
€3BSeries D
Lead